Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk factors of symptomatic NSAID-induced small intestinal injury and diaphragm disease.

Alimentary pharmacology & therapeutics - 1 Sept 2014

Ishihara M, Ohmiya N, Nakamura M, Funasaka K, Miyahara R, Ohno E, Kawashima H, Itoh A, Hirooka Y, Watanabe O, Ando T, Goto H

Abstract excerpt

BACKGROUND: The aetiology for nonsteroidal anti-inflammatory drug (NSAID)-induced small intestinal injuries has not been well characterised. AIM: To determine the risk factors of symptomatic NSAID-induced small intestinal injuries, including diaphragm disease. METHODS: Of the 1262 symptomatic pat...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents, Non-Steroidal
Share to Aryl Hydrocarbon Hydroxylases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aspirin

Share to Cytochrome P-450 CYP2C9

Share to Diaphragm

Share to Intestinal Diseases

Share to Intestine, Small

Share to Thiazoles

Source

Identifiers

PMID: 25041257
DOI: 10.1111/apt.12858

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25041257-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk factors of symptomatic NSAID-induced small intestinal injury and diaphragm disease.PMID 25041257Read ↗

Clinical and pharmacogenetic features of patients with upper gastrointestinal lesions at a multidisciplinary hospital: the role of nonsteroidal anti-inflammatory drugs.Semantic proximity Read ↗

An update on the pharmacogenomics of NSAID metabolism and the risk of gastrointestinal bleeding.Semantic proximity Read ↗

The influence of CYP2C19 polymorphisms on exacerbating effect of rabeprazole in celecoxib-induced small bowel injury.Semantic proximity Read ↗

Review article: cellular and molecular mechanisms of NSAID-induced peptic ulcers.Semantic proximity Read ↗

CYP2C9 variants as a risk modifier of NSAID-related gastrointestinal bleedingSemantic proximity Read ↗

Use of analgesics and nonsteroidal anti-inflammatory drugs, genetic predisposition, and bladder cancer risk in Spain.Semantic proximity Read ↗

Synergism interaction between genetic polymorphisms in drug metabolizing enzymes and NSAIDs on upper gastrointestinal haemorrhage: a multicenter case-control study.Semantic proximity Read ↗

Pharmacogenomics of non-steroidal antiinflammatory drug-induced gastrointestinal complicationsSemantic proximity Read ↗

Genetically based impairment in CYP2C8- and CYP2C9-dependent NSAID metabolism as a risk factor for gastrointestinal bleeding: is a combination of pharmacogenomics and metabolomics required to improve personalized medicine?Semantic proximity Read ↗

Nonsteroidal anti-inflammatory drugs and other analgesic use and bladder cancer in northern New England.Semantic proximity Read ↗

Novel single nucleotide polymorphism markers for low dose aspirin-associated small bowel bleeding.Semantic proximity Read ↗

Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.